Skip to main content
Implanet SA logo

Implanet SA — Investor Relations & Filings

Ticker · ALIMP ISIN · FR0013470168 LEI · 969500CIMHFWNM4J4V14 PA Manufacturing
Open in API
Filings indexed 266 across all filing types
Latest filing 2021-01-04 Report Publication Anno…
Country FR France
Listing PA ALIMP

About Implanet SA

http://www.implanet.com/en

Implanet is a medical technology company that designs, manufactures, and markets a range of implants and instruments for orthopedic surgery, with a specialized focus on spinal applications. The company's core offering is centered around its flagship Jazz™ platform, a latest-generation hybrid posterior fixation system intended to improve the treatment of various spinal disorders, including scoliosis. The product portfolio also includes other spinal systems such as Zeus™ and Saxxo™, Swingo™ interbody cages, Origin™ anterior cervical plates, and the Olea™ system for ultrasonic osteotomy. Additionally, Implanet provides complementary solutions like Neobone™ bone grafts. The company's products are utilized by surgeons and healthcare professionals in the field of spinal surgery.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Report Publication Announcement Classification · 98% confidence The document is titled "Implanet announces its 2021 financial calendar" and explicitly lists the dates for future financial events, including the publication of 2020 Full-Year Results, 2021 Quarterly Revenues, and the Annual General Meeting. This document is an announcement about the schedule of future corporate events and report publications, not the reports themselves. Given the options, the most appropriate classification for an announcement detailing the timing of future report releases is 'Report Publication Announcement' (RPA). The document length (2774 chars) is short, supporting the 'announcement' classification over the full report classification.
2021-01-04 English
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 95% confidence The document is titled "Implanet annonce son agenda financier 2021" (Implanet announces its 2021 financial calendar). It explicitly lists future dates for various financial events, such as annual revenue, annual results, and the Annual General Meeting (AGM). Since the document's primary purpose is to announce the schedule of future corporate events and reports, and it is very short (2925 characters), it fits the definition of a Report Publication Announcement (RPA) or a general regulatory announcement (RNS). Given that it specifically details the schedule for future report releases, RPA is the most precise fit, as it announces *when* reports will be published, rather than being the report itself. If the document were the actual AGM notice, it would be AGM-R, but this is just the schedule including the AGM date.
2021-01-04 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated November 4, 2020, announcing a distribution partnership in Mexico for Implanet's JAZZ® products following regulatory approval (Cofepris). It details business development, strategic goals, and includes quotes from management. It also mentions the next financial event (Annual Revenue 2020). This type of announcement, focusing on commercial agreements, regulatory milestones, and business updates outside of mandatory periodic financial filings (like 10-K or IR), typically falls under general corporate news or regulatory announcements. Since it is not a formal financial report (10-K, IR, ER, MRQ), nor a specific insider trade (DIRS), dividend notice (DIV), or capital change (CAP/SHA), it best fits the category for general regulatory/corporate announcements, which is RNS (Regulatory Filings) as a broad category for non-standard, material news, or potentially LTR if it were legal, but here it is commercial/regulatory news. Given the options, RNS serves as the best fit for a material press release announcing a commercial expansion contingent on regulatory approval, which is not covered by the more specific codes.
2020-11-04 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release dated November 4, 2020, announcing a new distribution agreement in Mexico for Implanet's JAZZ® platform products, following regulatory approval by Cofepris. It details a commercial partnership and includes commentary from the CEO. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is an announcement regarding business operations and commercial strategy, which often falls under general regulatory announcements or investor relations news. Since it is a specific business development announcement that doesn't fit the other specific categories (like M&A, Capital Change, or Director Dealing), the most appropriate general category for significant, non-financial-result-focused news is Regulatory Filings (RNS), which serves as a broad category for official company announcements not covered elsewhere. Given the content is a press release about a commercial agreement, RNS is the best fit among the provided options.
2020-11-04 English
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release dated October 19, 2020, announcing that Implanet and SeaSpine received FDA clearance for the Mariner Cap System. This announcement details a significant business development, partnership milestone, and product launch anticipation. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is a general corporate announcement regarding a strategic business event (FDA clearance/partnership success). Since it doesn't fit the specific categories like M&A (TAR), Capital (CAP), or Director Dealing (DIRS), the most appropriate general category for a significant, non-financial-result-focused corporate update is Regulatory Filings (RNS), which serves as a broad category for important announcements that don't fit elsewhere, although it is primarily a press release about a regulatory achievement (FDA clearance). Given the options, RNS is the best fit for a general corporate news announcement that isn't a standard financial report or specific corporate action notice.
2020-10-19 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a press release dated October 19, 2020, announcing that Implanet and SeaSpine have received FDA 510(k) clearance for the Mariner Cap System in the United States. This type of announcement, detailing a specific business development, regulatory approval, or partnership milestone, is typically classified as a general Regulatory Filing (RNS) if it doesn't fit a more specific category like M&A (TAR) or Capital Change (CAP). It is not an Earnings Release (ER), Interim Report (IR), Annual Report (10-K), or a presentation (IP). Since it is a formal announcement of a business/regulatory event that doesn't fit the other specific categories (like DIRS, DIV, NAV, etc.), the most appropriate general category is Regulatory Filings (RNS). The document length is substantial (6590 chars), so it is not a simple RPA.
2020-10-19 French

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.